Background: Glucocorticoids are involved in the regulation of metabolic, immunological, and developmental processes. Their synthesis is tightly controlled by feedback regulation through the hypothalamus-pituitaryadrenal (HPA) axis, allowing the organism to respond to stress in an adequate manner and to adapt to new situations. Disturbance of these regulatory mechanisms leads to major human diseases. By generating mice with
INTRODUCTION
Glucocorticoids are synthesized in the adrenal gland and are involved in regulating metabolic, immunological, and developmental processes. Most of their physiological effects are mediated by the glucocorticoid receptor (GR), a liganddependent transcription factor which belongs to the steroid receptor superfamily (1) . Although glucocorticoids bind to the mineralocorticoid receptor (MR) with higher affinity than to the GR, most of their effects are mediated via the GR, due to its wider expression and stronger transactivation potential. The generation of GR-deficient mice, by gene targeting in embryonic stem cells (2) , made it possible to address in detail the role of the GR in controlling the hypothalamus-pituitary-adrenal (HPA) axis.
The HPA axis, which is activated during stress response, has an adaptive and life-sustaining function. The induced release of glucocorticoids by the adrenal cortex is the final step of a neuroendocrine cascade that begins in the central nervous system (CNS) and converges on the neuroendocrine cells in the paraventricular nucleus (PVN) of the hypothalamus. Hypophysiotropic factors then drive transcription of the proopiomelanocortin (POMC) gene and secretion of its major product, the adrenocorticotrope hormone (ACTH), from the anterior lobe of the pituitary (AL) and, thereby, stimulate glucocorticoid release. The level of glucocorticoids is tightly controlled by feedback inhibition involv-Molecular Medicine, Volume 2, Number 6, November 1996 ing multiple components, including the pituitary, the hypothalamus, and the hippocampus. When corticosteroids are experimentally removed by adrenalectomy, a marked increase in transcription of the POMC gene in the AL and in the synthesis and secretion of ACTH are observed (3) . In contrast, it is not clear whether POMC gene expression in the neurointermediate lobe (NIL) is also under control of glucocorticoids (4) . In addition to its effects on the pituitary, adrenalectomy also removes the feedback signal for the hypothalamic peptides, corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP), leading to an increased biosynthesis of both factors (5, 6) . Acute stress is a potent activator of the HPA axis; interestingly, the HPA axis retains the ability to respond to repeated stress despite high levels of corticosterone in the blood. This maintenance of sensitivity to stress is thought to be mediated by switching from a steroid-dependent to a steroid-independent pathway during the modulation of the HPA axis, possibly by changing from CRH to AVP as the main ACTH secretagogue (7, 8) .
During development glucocorticoid synthesis starts at around Day E14 and peaks at birth (9) , whereas expression of the GR gene is already observed at Day E1O.5 (T. Cole, unpublished observation). In newborn mice carrying a targeted mutation in the GR locus, components of the HPA axis were found to be affected. The serum levels of corticosterone and ACTH, as well as the expression level of several stereoidogenic enzymes, were dramatically increased and the adrenal cortex showed a marked hypertrophy which was already evident at Day E15.5 (2) . As the GR is a key player in the feedback regulation of corticosterone synthesis and secretion via the HPA axis, further studies were necessary to elucidate in detail the mechanism by which it controls these two pathways.
The 
MATERIALS AND METHODS

GR-Mutant Animals and Genotyping
Mice with a targeted mutation in the glucocorticoid receptor gene (2) were housed under lightcontrolled conditions. GR-mutant embryos were obtained from heterozygous intercrosses and recovered by cesarian section. By convention, the day of the vaginal plug was counted as Day EO.5. Only littermates were compared in each experiment. Adult GR-mutant mice were matched and sacrificed at about 6 month of age.
For genotyping, a piece of the tail or the embryo was removed and digested with proteinase K overnight at 56°C. After DNA preparation the genotype was determined either by Southern blot (2) or by polymerase chain reaction (PCR) analysis. The sequence of the primers used in the PCR reaction are the following: PG/3, 5'-AGAATCCTTAGCTCCCCCTGG-3' (exon 2-specific, upstream of the insertion site); PG/4, 5'-CTGCTGCTTGGAATCTGCCTG-3' (exon 2-specific, downstream of the insertion site); PGK1, 5'-TGCCTGCTCTTTACTGAAGGCT-3' (specific to the PGK-terminator used in the neo-selection cassette). PCR was performed using an established protocol with an annealing temperature of 640C and 35 cycles. Amplified fragments were separated on a 1.5% agarose gel and visualized by ethidium bromide statiing. A 170-bp band represented the wild-type allele and a 450-bp band the mutant one.
RNA Isolation and RNase Protection Analysis Adult or embryonic heads were dissected and total RNA was isolated after homogenization in guanidinium thiocyanate (10) . Quantification and quality control was done by photometry at 260 nm/280 nm and by ethidium bromide staining of rRNAs after electrophoretic separation in denaturing agarose gels. RNase protection analysis was performed as previously described (11) using [32P] -aUTP-labeled antisense RNA probes.
A 338-bp subclone of the mouse TBP (TATAbinding protein) gene (12) and a 110-bp subclone of mouse COX (cytochrome oxidase 1) gene were used as internal controls to normalize the amount of protected fragments. The antisense probes were hybridized overnight against appropriate amounts of total RNA at 54°C in 80% formamide. Excess probes were removed by digestion with RNases A and TI and the protected fragments were analyzed on denaturing 5 % or 6% polyacrylamide gels. Gels were exposed to an autoradiographic filn and bands were subsequently quantified using the PhosphorImager system (Molecular Dynamics, Sunnyvale, CA).
For the synthesis of the 440-nt POMC antisense probe, a plasmid containing the whole coding region (kindly provided by J. Drouin) was linearized with NcoI and transcribed using T7-polymerase. For AVP, a plasmid containing the 230-bp SmaI/PstI-fragment of the rat cDNA (kindly provided by E. Mohr) was used to generate an antisense probe. The protected 110-nt fragment in mouse RNA preparations was shown to be reproducible and specific (data not shown). The MR probe was synthesized by linearizing the plasmid pmMRex2O.7P (kindly provided by S. Berger) with NcoI followed by transcription with T3-polymerase, yielding a 580-bp exon 2-specific probe.
In Situ Hybridization Embryos, embryonic heads, or adult brains were fixed in 4% paraformaldehyde in phosphatebuffered saline (PBS; pH 7.2) overnight, dehydrated through an ethanol series, cleared in toluene, and embedded in paraffin. Six-micrometer sections from each stage and tissue were sealed on TESPA-treated slides. In situ prehybridizations and hybridizations were carried out as described (13) . Hybridizations were done overnight at 58°C in 50% formamide using [35S]-aUTPlabeled antisense RNA probes at a concentration of 60 ng/ml. The first posthybridization wash was performed at 62°C, the second at 68°C, and both in 50% formamide. The final wash in 0.1X SSC at 55°C was done before dehydration of the sections. Slides were then dipped in Kodak NTB2 emulsion diluted 1:1 with water, exposed at 40C for 2 to 17 days, and developed using Kodak D 19 developing solution and Kodafix at 15iC for 4 min. Sections were stained using eosin and hematoxylin and visualized using a Zeiss Axiophot microscope.
The POMC plasmid (see above) was used to synthesize a 923-nt antisense probe covering the whole coding sequence of the mouse POMC gene. The CRH probe was made from a plasmid containing a 578-bp PstI-fragment from exon 2 of the mouse gene (kindly provided by A. Seasholtz). For AVP, the same rat cDNA clone described above was used to generate a 230-nt antisense probe. The specifity of all three probes was confirmed by the region-specific expression pattern.
RESULTS
POMC Gene Transcription in the Pituitary
Becomes Responsive to GR-Mediated Regulation between Days E14.5 and E16.5 of Development When adrenals are experimentally removed, the decrease in corticosterone levels in the blood leads to an increase in the transcription of the POMC gene in the anterior lobe of the pituitary, and an increased synthesis and secretion of ACTH. Similarly, in the absence of functional GR, feedback control via the HPA axis is impaired and a dramatic increase in ACTH levels is found in homozygous newborn mice (2) . Based on these observations, we wanted to investigate whether this increase in ACTH levels in the GRdeficient mice could be attributed to an up-regulation of POMC gene transcription and, also, at which point during development it occurs.
POMC mRNA levels were analyzed by in situ hybridization at stages E 14.5, E 16.5, and E 18.5, as well as in adult pituitaries. At E14.5, a clear signal was detected in the AL but not in the NIL. A qualitative comparison of POMC mRNA level in the AL of wild-type and mutant animals showed no difference (Fig. 1) . However, analysis of El 6.5 embryos revealed a dramatic difference. Here, the expression level of the POMC gene was found to be much higher in mutants than in wild-type animals (Fig. 1) . It thus appears that suppression of POMC transcription by the GR becomes effective starting at around Day E16.5 of development. A surprising observation was made with regard to POMC expression in the NIL: a strong reduction in POMC mRNA levels was observed in mutant animals compared with wild-type (Fig. 1) . This shows that expression of the POMC gene is regulated in an opposite manner in the two lobes of the pituitary.
When E18.5 and adult pituitaries were analyzed, the overall level of POMC expression was slightly increased, but the observed qualitative difference in expression between wild-type and mutant animals remained the same. This difference was more pronounced in E 18.5 fetuses than in adults.
In order to estimate the magnitude of the changes in POMC mRNA levels, pituitaries of adult mice were dissected, AL and NIL/PL were separated, and RNA was prepared. Pooled fractions were analyzed for POMC mRNA levels by RNase protection assays and quantified as described in Materials and Methods. In the AL, POMC expression increased by 72% in GR-mu-t P * r ; _ r;@.^5Wt * s s s s 5 6 -l -l R @ e ; e e | > j l v tants compared with wild-type animals, whereas in the NIL it decreased to 30% of that in wildtype animals (Fig. 2) . The absolute expression level of POMC is much higher in the NIL (approximately 14-fold, indicated by a different scale in the figure) due to the fact that it represents a nearly pure population of POMC-expressing melanotrophes, whereas the corticotrophes in the AL make up only about 10% of the hormone-producing cells. By comparing the in situ hybridization data obtained from embryonic and adult pituitaries, it can be estimated that the increase of POMC expression in the embryonic AL is much higher than the one observed in adults, whereas the differences observed in the NIL seem to be roughly the same at all stages of development after E16.5 (data not shown).
CRH Expression Is Increased in GR-Mutant Mice Starting around E16.5 of Development It has been known for some time that an additional level of the feedback regulation of glucocorticoid production exists in the hypothalamus. In particular, CRH, which is the main secretagogue for ACTH, is thought to be under control of the GR. Therefore, we analyzed mRNA levels of CRH in different regions of the brain of wild-type and mutant animals.
Fetal and adult brains were analyzed by in situ hybridization. The first time point used was EL16.5; a strong and selective signal in the PVN of the hypothalamus was obtained in wild-type animals. When mutants of the same stage were analyzed, a slight but reproducible increase in CRH transcription in the PVN was observed (Fig. 3) . The magnitude of this effect was estimated to correspond to about a 50% increase. In adult brains, CRH mRNA expression was increased 2-fold in mutant animals. To test if the observed effect was specific, mRNA levels in other regions of the adult brain known to express CRH (14) (Fig. 4) . To address the question of whether changes in individual nuclei of the hypothalamus occur, adult brains were analyzed by in situ hybridization. Changes in AVP expression were not observed in either the PVN, the SON (Fig. 5) lack of functional GR could influence expression of the MR.
Total RNA obtained from hippocampi of adult wild-type and mutant mice was prepared and analyzed by RNAase protection. Surprisingly, no change in the overall expression level of MR could be demonstrated (Fig. 6) . Although, regional differences in expression within the hippocampus would not be detected by the methodology employed, it seems unlikely that an increase in one area compensated for a decrease in another. Therefore, it can be concluded that MR expression is not directly controlled by the GR. In addition to dopamine, epinephrine released from the adrenal medulla is believed to be involved in the stress-induced increase of aMSH secretion from the NIL. Epinephrine acts in the NIL via the ,B-adrenergic receptors that are positively coupled to adenylate cyclase, leading to a synergistic effect in the inhibition of dopamine secretion. In GR-mutant mice, epinephrine is dramatically reduced in the blood (2); also, corticosterone cannot inhibit the dopaminergic system via the GR. These combined effects could converge intracellularly by reducing the cAMP levels in melanotrophe cells and thereby inhibit POMC transcription in the NIL, possibly via the transcription factor CREB. The idea that the decrease in the POMC mRNA levels can be attributed, at least in part, to a deregulation of the dopaminergic system is supported by a report that the effects of pharmacological substances are smaller in males than in females (24) , an observation that has also been made in adult GRmutants (unpublished data). Further studies will be necessary to analyze this mechanism in more detail.
Hypothalamic Expression of CRH and AVP The feedback inhibition of the HPA axis is known to involve multiple components, including the hypothalamus. We found a marked difference in the expression of CRH and AVP, the main ACTH secretagogues in the hypothalamus. CRH transcription was already increased in the paraventricular nucleus of GR-deficient mice at Day E16.5; in contrast, there was no change in AVP expression in any area of the hypothalamus.
It has often been speculated that there are two different pathways by which POMC can be activated in the pituitary: a steroid-sensitive one and a steroid-insensitive one (7) . If animals are acutely stressed, this leads to an up-regulation of CRH but not AVP expression. After repeated stress, however, the increase in AVP expression is much greater than that in CRH, and this happens despite high levels of glucocorticoids in the blood (26) . Obviously, CRH can be effectively suppressed by glucocorticoids, whereas AVP seems to be inducible under high corticosterone conditions. This suggests that a shift from CRH to AVP as the main ACTH secretagogue occurs in order to maintain the ability of the animal to respond to stress. This model is now supported by our observation with GR-mutant mice, which show a different regulation of both genes by the GR. In addition, the results are in agreement with those obtained with CRH-deficient mice (27) . These mice also do not show a difference in AVP expression, despite significantly decreased levels of corticosterone.
MR Expression in the Hippocampus
The control of the HPA axis by influences like behavior or immune challenge is thought to be mediated in part by the hippocampus. From various experiments, it can be concluded that the mRNA levels for the GR and the MR are subject to negative feedback regulation (28, 29) , and, since the GR is missing in GR-mutant animals, one might expect that MR expression would be altered. However, when we analyzed MR expression in the hippocampus, we found it to be indistinguishable in all three genotypes. We conclude from this that the expression of the MR mRNA is not under control of the GR.
Prenatal Control of the HPA Axis One of the most interesting findings was that both POMC and CRH gene expression are sensitive to GR-mediated regulation as early as Day E16.5 of development. This sheds new light on the phenomenon that prenatal experiences may influence the HPA axis in adulthood. Stress during pregnancy, as well as immunological challenge of the mother, was shown to be manifested in a change of HPA axis activity in the adult offspring (30) . The observation that the expression level of key genes, like POMC and CRH, is sensitive to changes in the corticosterone level in fetal development offers a possible explanation as to how stress and immunreactions could exert their influence on the HPA axis at this early stage. It is hypothesized that during the period when the HPA axis becomes established increased glucocorticoid levels could set a new nominal value to which the system gets adapted, resulting in an impaired HPA axis in adulthood. Clinically, one may postulate that prenatal stress could therefore increase the susceptibility to psychiatric disorders like depression and schizophrenia later in life.
Conclusion
In conclusion, the present experiments show that the HPA axis is sensitive to GR-mediated regulation as early as Day El 6.5 of development. POMC in the pituitary and CRH in the PVN of the hypothalamus represent genes that are under direct control of the GR; in contrast, a similar type of regulation could not be shown for hypothalamic AVP and hippocampal MR expression. The experiments presented here represent an initial approach to analyzing the basal regulation of the HPA axis in GR-mutant mice. It will be important in the future to determine how this altered system reacts to stressors and whether compensatory mechanisms or steroid-insensitive pathways allow the GR-mutant mice to respond to stress despite the high basal corticosterone levels.
